Meeting
2022 ASCO Annual Meeting
The impact of HRD in patients with pancreatic adenocarcinoma undergoing surgical resection: An updated analysis.
Authors
Gudbjorg Jonsdottir
University of Iowa Hospitals and Clinics, Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, Iowa City, IA
Gudbjorg Jonsdottir , Asgeir Thor Masson , Laura S. Jacobus , Michelle L. Churchman , Stephen B. Edge , Anne M. Noonan , Michael J. Cavnar , Susanna Varkey Ulahannan , Ibrahim Halil Sahin , Carlos Hou Fai Chan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4132)
DOI
10.1200/JCO.2022.40.16_suppl.4132
Abstract #
4132
Poster Bd #
118
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2022 ASCO Gastrointestinal Cancers Symposium
The impact of germline and somatic mutations in the homologous recombination repair pathway in pancreatic cancer patients who undergo perioperative chemotherapy.
First Author: Gudbjorg Jonsdottir
Poster
2021 ASCO Annual Meeting
Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.
First Author: Jessica A Lavery